AQST peer analysis
Aquestive Therapeutics (AQST) against its competitors: price, today's move, 1-year return and market value side by side.
AQST and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALKS Alkermes | $45.66 | 1.73% | 48.75% | $7.53B |
| AMPH Amphastar Pharmaceuticals | $27.12 | 0.33% | 6.35% | $1.15B |
| AYTU Aytu BioPharma | $1.94 | 0.52% | -14.54% | $21.08M |
| COLL Collegium | $23.75 | 0.30% | -34.03% | $770.92M |
| CPIX Cumberland Pharmaceuticals | $4.22 | -10.02% | 41.14% | $63.23M |
| DERM Journey Medical | $4.79 | -7.35% | -41.01% | – |
| SUPN Supernus Pharmaceuticals | $28.13 | -32.90% | -50.21% | $2.44B |
| VNDA Vanda Pharmaceuticals | $3.67 | -5.41% | -15.63% | $234.62M |
| XERS Xeris Biopharma | $10.36 | 1.82% | 6.75% | $1.85B |
| ZVRA Zevra Therapeutics | $10.27 | 1.68% | 0.88% | – |
| AQST Aquestive Therapeutics | $3.79 | 0.53% | -44.43% | $473.18M |
- AQST's peers: ALKS (Alkermes), AMPH (Amphastar Pharmaceuticals), AYTU (Aytu BioPharma), COLL (Collegium), CPIX (Cumberland Pharmaceuticals), DERM (Journey Medical), SUPN (Supernus Pharmaceuticals), VNDA (Vanda Pharmaceuticals).
Updated 2026-11-05 12:51 UTC